Related Experiment Video
Updated: Apr 21, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Retroperitoneal fibrosis associated with propranolol: a case report; is corticosteroid administration necessary after
Majid Shirani1, Azadeh Davoudian1, Abolghasem Sharifi2
1Department of Urology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Introduction:
Retroperitoneal fibrosis is a rare disease. It can be primary (Ormond's disease) or secondary to inflammation, malignancy or some drugs. Beta-adrenergic blockers including propranolol can cause the retroperitoneal fibrosis disease.
Case:
A 44-year-old woman who was taking propranolol for 13 years came to our center with complaints of oliguria and uremia symptoms (malaise, nausea and vomiting). After some investigations, it was found that the disease was retroperitoneal fibrosis. In the first step, she was treated with corticosteroids and then because of inadequate response, bilateral ureterolysis was performed. Then, an additional course of corticosteroid therapy was required after surgery.
Conclusion:
Retroperitoneal fibrosis is an unknown cause disease that can involve ureters and can cause obstructive symptoms. The imaging procedure of choice for diagnosis is abdominal CT scanning with oral and intravenous contrast agents. Corticosteroids are the first option for treatment, however, if they are not effective and in case of severe obstruction, ureterolysis can be performed. Beta- adrenergic blocker drugs that are widely used in heart diseases can be a cause of retroperitoneal fibrosis.
More Related Videos
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Urinary Tract Calculi VI: Surgical Management

